CH Biotech R&D Co., Ltd. (TPE:6534)
90.70
-1.30 (-1.41%)
Sep 11, 2026, 1:30 PM CST
| Market Cap | 9.14B -25.6% |
| Revenue (ttm) | 1.87B +11.3% |
| Net Income | 604.70M +66.0% |
| EPS | 5.88 +66.6% |
| Shares Out | 100.80M |
| PE Ratio | 15.43 |
| Forward PE | n/a |
| Dividend | 5.31 (5.83%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 70,515 |
| Open | 91.00 |
| Previous Close | 92.00 |
| Day's Range | 90.40 - 91.80 |
| 52-Week Range | 77.60 - 119.00 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |